Dynavax Technologies Competitors and Similar CompaniesClear all
Dynavax Technologies's competitors and similar companies include Livzon Pharmaceutical Group and UCB.
 Dynavax Technologies Dynavax Technologies Corporation is a biopharmaceutical company discovering and developing novel products to prevent and treat infectious, autoimmune and inflammatory diseases, and the treatment of cancer. |  Livzon Pharmaceutical Group Livzon Pharmaceutical Group (丽珠医药集团股份有限公司, 丽珠医药) is a pharmaceutical company that engages in the development and production of active pharmaceutical ingredients, biological drugs, diagnostic reagents, and other products. |  UCB UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions. | |
Founding Date | Founding Date 1996 | Founding Date 1985 | Founding Date 1928 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations Emeryville, US HQ Düsseldorf, DE Berkeley, US | Locations Zhuhai, CN HQ Chengdu, CN Qingyuan, CN Shanghai, CN Shaoguan, CN Shenzhen, CN Zhuhai, CN | Locations Brussels, BE HQ Melbourne, AU Vienna, AT Braine L'alleud, BE Braine L'alleud, BE Leuven, BE São Paulo, BR see more |
Employees | Employees 24946% increase | Employees 9,067 | Employees 9,052 |
Valuation ($) | Valuation ($) 1.5 b | Valuation ($) 4.2 b | Valuation ($) 34.3 b |
Financial | |||
Revenue (est.) | Revenue (est.) $277.2m (FY, 2024) | Revenue (est.) ¥11.7b (FY, 2025) | Revenue (est.) €7.4b (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods ¥4.1b (FY, 2025) | Cost of goods €1.4b (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit ¥7.8b (FY, 2025) | Gross profit €7.2b (FY, 2025) |
Net income | Net income $27.3m (FY, 2024) | Net income ¥2.4b (FY, 2025) | Net income €1.6b (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
Livzon Pharmaceutical Group
HQ
Zhuhai, CN
Employees
9,067
Livzon Pharmaceutical Group (丽珠医药集团股份有限公司, 丽珠医药) is a pharmaceutical company that engages in the development and production of active pharmaceutical ingredients, biological drugs, diagnostic reagents, and other products.
View companyUCB
HQ
Brussels, BE
Employees
9,052
UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions.
View company